Biotech News
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
ir.enliventherapeutics.com2026-05-06 14:55 EST
In the news release, Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update, issued 12-Nov-2025 by Enliven Therapeutics, Inc. , the Company clarified details surrounding the status of the Phase 1b portion of the ENABLE clinical trial of ELVN-001 in CML.